Related references
Note: Only part of the references are listed.Bufotalin induces ferroptosis in non-small cell lung cancer cells by facilitating the ubiquitination and degradation of GPX4
Wen Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2022)
Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance
Tianqi Liu et al.
NEURO-ONCOLOGY (2022)
Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression
Shiyao Sui et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Ferroptosis and its Role in Gastric Cancer
Renjun Gu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
The Critical Role of Ferroptosis in Hepatocellular Carcinoma
Fan Pan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Targeting ferroptosis as a vulnerability in cancer
Guang Lei et al.
NATURE REVIEWS CANCER (2022)
Ferroptosis: machinery and regulation
Xin Chen et al.
AUTOPHAGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Broadening horizons: the role of ferroptosis in cancer
Xin Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
Joseph Chao et al.
JAMA ONCOLOGY (2021)
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Yelena Y. Janjigian et al.
LANCET (2021)
Ferroptosis in the tumor microenvironment: perspectives for immunotherapy
Huanji Xu et al.
TRENDS IN MOLECULAR MEDICINE (2021)
Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer
Y. Jiang et al.
ANNALS OF ONCOLOGY (2020)
The vicious cycle between ferritinophagy and ROS production triggered EMT inhibition of gastric cancer cells was through p53/AKT/mTor pathway
Zhongjie Xu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Emerging Mechanisms and Disease Relevance of Ferroptosis
Brent R. Stockwell et al.
TRENDS IN CELL BIOLOGY (2020)
Characterization of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma to Aid Immunotherapy
Xinhai Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Tumor microenvironment and metabolic factors: contribution to gastric cancer
L. Bubnovskaya et al.
Experimental Oncology (2020)
FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations
Nan Zhou et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2020)
Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures
Dongqiang Zeng et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation
Wenjun Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang et al.
NATURE (2019)
Interferon-γ induces cancer cell ferroptosis
Laurence Zitvogel et al.
CELL RESEARCH (2019)
A pooled single-cell genetic screen identifies regulatory checkpoints in the continuum of the epithelial-to-mesenchymal transition
Jose L. McFaline-Figueroa et al.
NATURE GENETICS (2019)
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
Xueting Lang et al.
CANCER DISCOVERY (2019)
Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer
Yuming Jiang et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
Jose Pedro Friedmann Angeli et al.
NATURE REVIEWS CANCER (2019)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2018)
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
Kohei Shitara et al.
LANCET (2018)
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Daniele V. F. Tauriello et al.
NATURE (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim et al.
NATURE MEDICINE (2018)
Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype
Sang Cheul Oh et al.
NATURE COMMUNICATIONS (2018)
Ferroptosis: A Novel Anti-tumor Action for Cisplatin
Jipeng Guo et al.
CANCER RESEARCH AND TREATMENT (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
ImmunoScore Signature A Prognostic and Predictive Tool in Gastric Cancer
Yuming Jiang et al.
ANNALS OF SURGERY (2018)
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Yoon-Koo Kang et al.
LANCET (2017)
A Transcriptional Program for Detecting TGFβ-Induced EMT in Cancer
Momeneh Foroutan et al.
MOLECULAR CANCER RESEARCH (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Vasanthi S. Viswanathan et al.
NATURE (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Monitoring immune-checkpoint blockade: response evaluation and biomarker development
Mizuki Nishino et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells
Yana Zavros
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
Jakob Hedegaard et al.
CANCER CELL (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
Priti S. Hegde et al.
CLINICAL CANCER RESEARCH (2016)
The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells
Christophe Louandre et al.
CANCER LETTERS (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu et al.
NATURE MEDICINE (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Yoshinari Asaoka et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
Xun Yuan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
Jeffrey S. Damrauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
Christophe Louandre et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
A Molecular Taxonomy for Urothelial Carcinoma
Gottfrid Sjodahl et al.
CLINICAL CANCER RESEARCH (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
The Human Protein Atlas as a proteomic resource for biomarker discovery
F. Ponten et al.
JOURNAL OF INTERNAL MEDICINE (2011)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Consensus clustering: A resampling-based method for class discovery and visualization of gene expression microarray data
S Monti et al.
MACHINE LEARNING (2003)
Share Paper
